BioSpace News Archive

EHO360 is an experienced national Hospice Pharmacy Benefit Manager with a deep understanding of the hospice system with hospice provider clients across the country.

Neurogene Inc. , a company founded with a mission to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the U.S. Fo

BIOASIS TECHNOLOGIES INC. announced that it has granted stock options to acquire a total of 1,495,000 common shares effective June 30, 2020 at a price of $0.31 per share to directors and officers of the company.

Medical technology and data company Neural Analytics, Inc. announced a name change and rebranding as NovaSignal Corp., representing its expansion into new markets and accelerated commercialization of its life-saving solutions that measure blood flow in the brain. NovaSignal aims to make measuring blood flow to the brain widespread, personal, and portable. Its goal is to make this measurement the “fifth vital sign” along with body temperature, bl

Tessera Therapeutics emerges from three years of stealth operations to pioneer Gene Writing™ as a new genome engineering technology and category of genetic medicine

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced it has completed its acquisition of Quantitative Medicine LLC (“QM”), a biomedical analytics and computational biology company, in an all-stock transaction valued at approximately $1.8 million.

The collaboration with Numab Therapeutics expands Boehringer Ingelheim’s bi- and multi-specific antibody pipeline with two front-runner projects in lung and gastrointestinal (GI) cancer and geographic atrophy (GA) Numab’s proprietary platform enables the engineering of first-in-class and best-in-class bi- and multi-specific antibodies in a true plug-and-play fashion

Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) clearance and CE ( Conformité Européenne ) Mark approval for its LINQ II™ insertable cardiac monitor (ICM) with remote programming, which enables clinicians to optimize device settings without the need for patients to ret

ivWatch, LLC, a pioneer in biosensor technology, has received FDA clearance for its new SmartTouchTM disposable sensor for the early detection of peripheral IV infiltration and extravasation events.

International medical imaging IT and cybersecurity company Sectra will install its enterprise imaging solution in many of CHRISTUS Health’s U.S. locations.